Profile data is unavailable for this security.
About the company
HBM Holdings Ltd is an investment holding company mainly engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. The Company’s products include batoclimab, mainly used for immune thrombocytopenia (ITP), graves’ ophthalmopathy (GO), myasthenia gravis (MG), neuromyelitis optica spectrum disorder (NMOSD); and tanfanercept, mainly used for dry eye disease (DED). In addition, the Company researches and develops immuno-oncology portfolio, including internally developed next-generation immune-oncology assets targeting immune-desert, immune-excluded and inflamed tumors.
- Revenue in HKD (TTM)562.07m
- Net income in HKD165.79m
- Incorporated2016
- Employees158.00
- LocationHbm Holdings LtdLevel 54, Hopewell Centre, 183Queen's Road East, Wan ChaiSUZHOU ChinaCHN
- Websitehttps://www.harbourbiomed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3D Medicines Inc | 525.15m | -483.15m | 506.09m | 193.00 | -- | 0.5556 | -- | 0.9637 | -2.05 | -2.05 | 2.20 | 3.53 | 0.3746 | 4.94 | 5.79 | 2,652,296.00 | -37.27 | -- | -50.88 | -- | 91.97 | -- | -99.50 | -- | 2.56 | -- | 0.2517 | -- | 11.91 | -- | 48.78 | -- | -- | -- |
| Fusen Pharmaceutical Co Ltd | 457.12m | -96.34m | 665.37m | 1.14k | -- | 1.21 | -- | 1.46 | -0.1292 | -0.1292 | 0.6136 | 0.7456 | 0.3212 | 1.68 | 5.01 | 398,190.20 | -6.77 | 0.9678 | -13.96 | 1.74 | 53.18 | 51.95 | -21.08 | 2.59 | 0.526 | -2.10 | 0.4031 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.20bn | 63.06m | 688.94m | 993.00 | 10.93 | 0.402 | 3.51 | 0.5746 | 0.1071 | 0.1071 | 2.04 | 2.91 | 0.4403 | 2.11 | 9.70 | 1,134,410.00 | 1.98 | 13.33 | 2.52 | 17.76 | 51.49 | 61.92 | 4.50 | 36.20 | 0.7425 | 6.58 | 0.132 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |
| Zhaoke Ophthalmology Ltd | 61.47m | -243.94m | 731.83m | 297.00 | -- | 0.335 | -- | 11.91 | -0.4478 | -0.4478 | 0.1128 | 4.00 | 0.0233 | 1.25 | 16.09 | 196,383.80 | -9.23 | -- | -10.51 | -- | 82.03 | -- | -396.86 | -- | 5.48 | -24.02 | 0.1114 | -- | -- | -- | 5.47 | -- | -- | -- |
| Pak Fah Yeow International Ltd | 265.21m | 96.45m | 747.94m | 101.00 | 7.76 | 0.9954 | 7.21 | 2.82 | 0.3094 | 0.3094 | 0.8507 | 2.41 | 0.2869 | 2.84 | 23.53 | 2,600,118.00 | 10.44 | 3.99 | 11.32 | 4.18 | 87.05 | 80.79 | 36.37 | 21.27 | 4.22 | 5.26 | 0.0055 | 100.68 | 76.06 | 12.94 | 250.66 | 23.02 | 18.83 | -8.06 |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 901.37m | 184.40m | 767.54m | 678.00 | 4.16 | 0.4508 | 6.20 | 0.8515 | 0.3291 | 0.3291 | 1.61 | 3.04 | 0.3574 | 2.10 | 2.94 | 1,062,936.00 | 7.31 | 7.67 | 10.25 | 10.48 | 75.46 | 78.79 | 20.46 | 20.68 | 1.62 | -- | 0.0502 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.20bn | 119.59m | 820.42m | 2.74k | 6.73 | 0.69 | 3.55 | 0.3736 | 0.1412 | 0.1412 | 2.59 | 1.38 | 1.09 | 2.68 | 7.39 | 830,815.60 | 5.99 | 7.69 | 9.17 | 11.75 | 57.55 | 60.44 | 5.49 | 6.73 | 0.9033 | 213.59 | 0.1516 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | -- |
| Hbm Holdings Ltd | 562.07m | 165.79m | 918.02m | 158.00 | 5.33 | 0.9218 | 4.68 | 1.63 | 0.2254 | 0.2254 | 0.7624 | 1.30 | 0.3258 | 3.96 | 16.67 | 3,175,517.00 | 9.59 | -54.61 | 13.25 | -66.04 | 95.57 | 97.81 | 29.42 | -400.28 | 3.44 | 8.14 | 0.3502 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
| SinoMab Bioscience Ltd | 2.18m | -214.48m | 1.18bn | 214.00 | -- | 3.96 | -- | 541.71 | -0.2059 | -0.2059 | 0.0021 | 0.2725 | 0.0023 | -- | -- | 10,123.74 | -22.83 | -24.62 | -29.11 | -27.72 | 26.80 | -- | -9,853.75 | -4,451.74 | -- | -81.79 | 0.6339 | -- | -- | -- | 14.45 | -- | 106.81 | -- |
Data as of Nov 26 2024. Currency figures normalised to Hbm Holdings Ltd's reporting currency: Hong Kong Dollar HKD
0.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 5.77m | 0.75% |
| SSgA Funds Management, Inc.as of 07 Nov 2024 | 1.16m | 0.15% |
| DFA Australia Ltd.as of 30 Sep 2024 | 106.50k | 0.01% |
| Dimensional Fund Advisors Ltd.as of 31 Aug 2024 | 41.77k | 0.01% |
| China Asset Management (Hong Kong) Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2024 - 21 Nov 2024Source: FactSet Research Systems Inc.
